Yuanlong Hu
Biographic Data
| ID | 6822447 |
|---|---|
| NAME | Yuanlong Hu |
| GIVEN NAMES | Yuanlong |
| FAMILY NAME | Hu |
| SIGNATURE | HU Y |
| AFFILIATIONS | Shandong University of Traditional Chinese Medicine |
| ORCID | 0000-0003-1933-7570 |
| VERIFIED | Yes |
| TOTAL WORKS | 3 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 3 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2023 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 0 |
Quanzhenyiqitang and its polysaccharides alleviate chronic obstructive pulmonary disease inflammatory injury through TLR4/MyD88/Mapk signaling pathway
Persistence of severe global inequalities in the burden of Hypertension Heart Disease from 1990 to 2019
The unequal prevalence of HHD across different populations can hinder the achievement of the "health for all" objective. Persistent disparities in HHD have been observed globally over the past thirty years. It is crucial to prioritize efforts towards reducing avoidable health inequalities associated with hypertension-related heart disease, particularly in low-income and middle-income countries
Association of systemic inflammatory biomarkers with depression risk
Systemic inflammatory biomarkers (SII and SIRI) significantly affected the risk of depression. SII or SIRI can serve as a biomarker of anti-inflammation treatment for depression
No prominent works on this page.
Association of systemic inflammatory biomarkers with depression risk
Systemic inflammatory biomarkers (SII and SIRI) significantly affected the risk of depression. SII or SIRI can serve as a biomarker of anti-inflammation treatment for depression
Persistence of severe global inequalities in the burden of Hypertension Heart Disease from 1990 to 2019
The unequal prevalence of HHD across different populations can hinder the achievement of the "health for all" objective. Persistent disparities in HHD have been observed globally over the past thirty years. It is crucial to prioritize efforts towards reducing avoidable health inequalities associated with hypertension-related heart disease, particularly in low-income and middle-income countries
Quanzhenyiqitang and its polysaccharides alleviate chronic obstructive pulmonary disease inflammatory injury through TLR4/MyD88/Mapk signaling pathway
Internal Medicine (3 works) · Medicine (3 works) · Environmental health (2 works) · Inflammation (2 works) · Population (2 works) · Andrographolide Research and Applications (1 work) · Biochemistry (1 work) · Biochemistry (1 work) · Biology (1 work) · Biostatistics (1 work)